Feasibility and prognostic role of machine learning-based FFRCT in patients with stent implantation
- 17 April 2021
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 31 (9) , 6592-6604
Abstract
Objectives To investigate the feasibility and prognostic implications of coronary CT angiography (CCTA) derived fractional flow reserve (FFRCT) in patients who have undergone stents implantation. Methods Firstly, the feasibility of FFRCT in stented vessels was validated. The diagnostic performance of FFRCT in identifying hemodynamically in-stent restenosis (ISR) in 33 patients with invasive FFR ≤ 0.88 as reference standard, intra-group correlation coefficient (ICC) between FFRCT and FFR was calculated. Secondly, prognostic value was assessed with 115 patients with serial CCTA scans after PCI. Stent characteristics (location, diameter, length, etc.), CCTA measurements (minimum lumen diameter [MLD], minimum lumen area [MLA], ISR), and FFRCT measurements (FFRCT, ΔFFRCT, ΔFFRCT/stent length) both at baseline and follow-up were recorded. Longitudinal analysis included changes of MLD, MLA, ISR, and FFRCT. The primary endpoint was major adverse cardiovascular events (MACE). Results Per-patient accuracy of FFRCT was 0.85 in identifying hemodynamically ISR. FFRCT had a good correlation with FFR (ICC = 0.84). 15.7% (18/115) developed MACE during 25 months since follow-up CCTA. Lasso regression identified age and follow-up ΔFFRCT/length as candidate variables. In the Cox proportional hazards model, age (hazard ratio [HR], 1.102 [95% CI, 1.032–1.177]; p = 0.004) and follow-up ΔFFRCT/length (HR, 1.014 [95% CI, 1.006–1.023]; p = 0.001) were independently associated with MACE (c-index = 0.856). Time-dependent ROC analysis showed AUC was 0.787 (95% CI, 0.594–0.980) at 25 months to predict adverse outcome. After bootstrap validation with 1000 resamplings, the bias-corrected c-index was 0.846. Conclusions Noninvasive ML-based FFRCT is feasible in patients following stents implantation and shows prognostic value in predicting adverse events after stents implantation in low-moderate risk patients. Key Points • Machine-learning-based FFRCT is feasible to evaluate the functional significance of in-stent restenosis in patients with stent implantation. • Follow-up △FFRCT along with the stent length might have prognostic implication in patients with stent implantation and low-to-moderate risk after 2 years follow-up. The prognostic role of FFRCT in patients with moderate-to-high or high risk needs to be further studied. • FFR CT might refine the clinical pathway of patients with stent implantation to invasive catheterization.Keywords
Funding Information
- General Project of Chinese Postdoctoral Science Foundation (2020M673677)
- National Key Research and Development Program of China (2017YFC0113400)
This publication has 28 references indexed in Scilit:
- Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trialThe Lancet, 2015
- Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysisThe Lancet, 2015
- Coronary In-Stent Restenosis: Assessment with Corrected Coronary Opacification Difference across Coronary Stents Measured with CT AngiographyRadiology, 2015
- Role of Cardiac Multidetector Computed Tomography Beyond Coronary AngiographyCirculation Journal, 2015
- Prognostic Value of Fractional Flow ReserveJACC, 2014
- Current Treatment of In-Stent RestenosisJACC, 2014
- Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantationEuroIntervention, 2014
- A Novel Noninvasive Technology for Treatment Planning Using Virtual Coronary Stenting and Computed Tomography-Derived Computed Fractional Flow ReserveJACC: Cardiovascular Interventions, 2014
- Long-Term Safety and Efficacy of Drug-Eluting versus Bare-Metal Stents in SwedenNew England Journal of Medicine, 2009
- Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of CardiologyEuropean Heart Journal, 2006